Crossmark

A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-

Crossref DOI link: https://doi.org/10.1007/s10147-020-01629-6

Published Online: 2020-02-14

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Kasai, Takashi http://orcid.org/0000-0002-3112-4001
Mori, Kiyoshi

Kishi, Kazuma

Kaburagi, Takayuki

Hosomi, Yukio

Imai, Hisao

Yamada, Yutaka

Yomota, Makiko

Moriguchi, Syuhei

Seike, Masahiro

Minato, Koichi

Gemma, Akihiko
Funding

Funding for this research was provided by:

The Tokyo Cooperative Oncology Group.
License Information

Text and Data Mining valid from 2020-02-14

Version of Record valid from 2020-02-14
More Information

Article History

Received: 15 August 2019

Accepted: 25 January 2020

First Online: 14 February 2020

Compliance with ethical standards

:

: No author has any conflict of interest.

Document is current

Any future updates will be listed below